A Fosamax lawsuit alleging femur fractures caused by the osteoporosis drug is scheduled to go to trial the second week in April, Bloomberg.com reports.

According to the article published Apr. 3, 2013, the trial slated to begin April 9 in New Jersey federal court in Trenton is the second of 3,300 Fosamax femur fracture lawsuits claiming broken legs to be heard in the U.S.

Many of these claims are pending in a federal multidistrict litigation (MDL) currently underway in the U.S. District Court for the District of New Jersey. An additional 1,230 cases alleging osteonecrosis of the jaw (ONJ) caused by use of the bisphosphonate have also been filed, Merck & Co. has said.

Second Trial for Fosamax Lawsuit Scheduled for April

A month ago, the first trial for a Fosamax femur fracture lawsuit was halted in Atlantic City, New Jersey, after the plaintiff experienced a “serious health complication” unrelated to her use of the drug used to treat women with osteoporosis. Information about the mistrial was included in a statement published March 18th on Merck’s website.

New research findings published in the Journal of Bone and Joint Surgery may have an impact on future trials for Fosamax lawsuits. Released Mar.1 in a report from News-Medical.net, U.S. scientists counted 362 reports of non-healing femoral fractures in the U.S. Food and Drug Agency Adverse Event Reporting System (FAERS) database. The ratio for these fractures and use of a bisphosphonate like bone-loss drug, Fosamax, was 4.51.

What’s more, the investigation revealed that 26% of atypical femoral fractures were non-healing. This may lend evidence to the possibility that “some of the non-healing femoral fractures in the FAERS database could well be atypical femoral fractures, according to researchers.

Approximately two months before the second Fosamax lawsuit trial was scheduled to begin, Merck & Co. voiced its expectations that company profit may sink this year due to a generic version of its best-selling drug, Singulair. Research efforts have also slowed the process of getting new drugs to market, Bloomberg states.

How to File a Fosamax Lawsuit

If you suffered a femur fracture after taking bone-loss drug, Fosamax, you may be eligible to file a claim against Merck & Co. Contact a lawyer at Bernstein Liebhard LLP to learn more about Fosamax lawsuits at (877) 779-1414.

Published April 4, 2013 by